[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"news-aggregator-william-blair-issues-optimisti330195945b-8d50-7453-9b7c-1158e52c956d":3},{"id":4,"timestamp":5,"title":6,"content":7,"link":8,"preview":9,"tags":10,"predictedTags":11,"showTags":12,"source":13,"reactions":14,"selfReactions":15,"logo":16,"sourceId":17,"sourceUserId":18,"asset":19,"tagsCategories":20,"totalComments":21,"lang":22,"unique_views_count":23,"enrichStatus":19},"william-blair-issues-optimisti330195945b-8d50-7453-9b7c-1158e52c956d","1741950751000","William Blair Issues Optimistic Outlook for BMY Earnings","Bristol-Myers Squibb (NYSE:BMY - Free Report) - Investment analysts at  William Blair upped their Q2 2025 earnings per share estimates for Bristol-Myers Squibb  in a note issued to investors on  Tuesday, March 11th. William Blair analyst M. Phipps now anticipates that the biopharmaceutical company w","https://www.marketbeat.com/instant-alerts/william-blair-issues-optimistic-outlook-for-bmy-earnings-2025-03-13/","https://www.marketbeat.com/images/marketbeat-logo-1200-1200.jpg?v=1","[]","[\"\",\"-\"]","[{\"name\":\"\",\"logo\":\"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/blockchains/.png\"},{\"name\":\"-\",\"logo\":\"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/protocols/-.png\"}]","33",[],[],"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/news-feeds/sources/market-beat.png","Market Beat",null,"","[\"Other\"]","0","EN","2"]